Logicboots Pvt. Ltd., a Delhi-based deep-tech company specializing in AI-powered healthcare technologies, has launched its flagship innovation, Coeur.AI, at Viva Technology Paris 2026. Coeur.AI is an AI-powered wireless stethoscope designed to support the initial screening of cardio-respiratory conditions. The device was introduced to the global innovation ecosystem during VivaTech Paris 2026, one of Europe's largest startup and technology events.
Inspiration and Vision Behind Coeur.AI
Founded by Amit Kumar Singh and Swarn lata, Logicboots aims to develop next-generation healthcare technologies that make early screening more accessible and affordable. The vision for Coeur.AI was inspired by the loss of Amit Kumar Singh's father due to delayed diagnosis and limited access to timely healthcare. This motivated the founders to create intelligent tools that can assist healthcare professionals in identifying potential conditions at an early stage.
Technical Capabilities of Coeur.AI
Coeur.AI combines advanced acoustic sensing, embedded electronics, and artificial intelligence to analyze heart and lung sounds. It assists healthcare professionals in the initial screening of conditions such as pneumonia, tuberculosis, asthma, COPD, and cardiac rhythm abnormalities. The portable device connects wirelessly with a companion application, enabling digital auscultation and secure data management.
Founder's Statement on Mission
"Our mission is to democratize intelligent diagnostics and empower healthcare professionals with affordable AI-enabled tools that can support initial screening and help reduce delays in identifying potential cardio-respiratory conditions," said Amit Kumar Singh, Founder and CEO of Logicboots Pvt. Ltd.
Global Accelerator Participation
Logicboots has been selected for several prestigious international programs. The company participated in the Harvard Foundry Bootcamp, was selected among the Top 18 startups globally for the Sisu Launchpad Accelerator in Helsinki, Finland, and has been chosen for the Maria 01 Northern Lights Accelerator, one of the Nordic region's leading startup programs. Coeur.AI was showcased at Viva Technology Paris 2026, reflecting the company's ambition to bring AI-enabled healthcare technologies developed in India to international markets.
Support from Indian Innovation Ecosystems
Logicboots is supported by leading Indian innovation ecosystems, including AIC IIT Delhi, MedTech Centre SGPGI Lucknow, and Software Technology Parks of India (STPI). The company is actively developing AI-powered healthcare technologies while positioning Indian deep-tech innovation on the global stage.
CEO's Remarks on Global Vision
"Presenting Coeur.AI at VivaTech Paris 2026 and participating in globally recognized accelerator programs validates our vision of building healthcare technologies from India for the world. We believe AI-assisted screening solutions can help improve access to timely care and strengthen primary healthcare systems worldwide," Singh added.
Future Plans and Commercialization
The company plans to undertake pilot studies and strengthen collaborations with hospitals, research institutions, and healthcare organizations for further validation and commercialization of Coeur.AI.
About Logicboots and Team
Logicboots Pvt. Ltd. is a Delhi-based deep-tech company focused on artificial intelligence and healthcare technologies. Founded by Amit Kumar Singh and Swarn lata, the company develops intelligent solutions aimed at improving access to affordable healthcare. Its flagship product, Coeur.AI, is an AI-powered wireless stethoscope platform designed to support initial screening of cardio-respiratory conditions and advance digital healthcare delivery. The team comprising Krishnankan, Aman, Mayank, and Parv worked day and night to turn this decade-old ambition into reality.
International Expansion Strategy
The company is currently expanding its operations with a strategic focus on Europe and the United States, leveraging global accelerator programs and partnerships to scale its AI-powered healthcare solutions internationally.
